How much funding has Capacity Bio raised?

Capacity Bio has raised $35.0M in total funding, most recently a Series A round.

Where is Capacity Bio headquartered?

Capacity Bio is headquartered in Los Angeles, California, United States.

What industry is Capacity Bio in?

Capacity Bio operates in Life Sciences.

How many employees does Capacity Bio have?

Capacity Bio has 1-10 employees.

Capacity Bio

Q: Who are Capacity Bio's investors?

Capacity Bio's investors include RA Capital Management, Insight Partners, Remiges Ventures.

The Mitophagy Company

Los Angeles, United States · $35.0M raised

Life Sciences

Headquarters: Los Angeles, California
Employees: 1–10
Business Model: B2B
Website: capacitybio.com

Total Funding: $35.0M
Last Round: $35.0M Series AMar 2023
Rounds: 1

About

Capacity Bio is a mitochondria-focused biotechnology company developing first-in-class therapeutics that enhance the body's mitophagy process — the cellular mechanism by which dysfunctional mitochondria are identified, removed, and replaced. The company's proprietary platform uses small molecules, peptides, and nanoparticles to activate mitophagy pathways implicated in aging, neurodegeneration, and metabolic disease. Headquartered in Los Angeles and with a Japanese subsidiary in Tokyo, Capacity Bio closed a $35 million financing round in March 2023 co-led by RA Capital Management and Insight Partners, with participation from existing investor Remiges Ventures. Its lead mitophagy agonist program was advancing toward clinical trials in 2024.

Summary

Capacity Bio is a Life Sciences company based in Los Angeles, United States. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Mar 2023. Investors include RA Capital Management, Insight Partners and Remiges Ventures.